iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States.
$0.74+1.16%
报价 2026-11-06
市值
$47.5M
EV
$-15.5M
PE (TTM)
–
预期 PE (FY2027)
–
52 周区间距高点 -75.9%
$0.71$3.07
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| IBIOiBio, Inc. | $47.5M | +1.2% | -50.0% | -160% | – | – | – | |
| ANTXAN2 Therapeutics, Inc. | $150.9M | +1.1% | +119.0% | 0% | – | – | – | |
| RLYBRallybio Corporation | $84.8M | +0.4% | -85.7% | 99.7% | – | – | – | |
| BOLDBoundless Bio, Inc. | $56M | +2.1% | – | 0% | – | – | – | |
| PLURPluri Inc. | $13.3M | +3.8% | – | 44.6% | – | – | – | |
| INTSIntensity Therapeutics, Inc. | $8.1M | -3.2% | – | 0% | – | – | – | |
| XCURExicure, Inc. | $6.2M | +6.7% | – | 0% | – | – | – | |
| CVKDCadrenal Therapeutics, Inc. Common Stock | $3.5M | -2.0% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +16.6% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。